The overall, long-term objective of this research program is to use genetic, immunological and molecular approaches to define the functions that the type 5 and type 12 adenovirus (Ad5 and Ad12) E1A and E1B proteins, and perhaps other viral proteins, play in transforming rat and mouse cells in vitro, and in regulating the events which occur in the early phase of the productive infection in human cells. A particular goal is to understand the basis for the strong oncogenicity of Ad12 in rodents and the striking difference in oncogenicity between that serotype and the non-oncogenic type 5 virus. To this end we have constructed and are characterizing Ad12 and Ad5-based viruses containing chimeric E1A genes, and have used some of these, and point mutants, to identify an oncogenic determinant of Ad 12 located to the spacer region between conserved regions 2 and 3 of the E1A gene.
The specific aims of this program over the next five years are to: a. Continue phenotypic analysis of the Ad12-based viruses with chimeric E1A genes, and of rat and mouse cells transformed by these viruses, with a view to defining the potential influence of the E1A spacer region on immunological and other host-related factors which help to shape transformed cell tumorigenicity. b. Continue mutational analysis of the Ad12 E1A nonconserved spacer region which acts as a determinant of oncogenicity. c. Expand the chimeric approach to determine if other E1A regions are required for oncogenicity. d. Carry out phenotypic analysis of the Ad5-based chimeric viruses which carry the Ad12 spacer region and other regions, and determine if the spacer segment can act autonomously. e. Define the molecular basis for the role of the Ad12 E1A spacer region in oncogenic transformation. f.Assess the roles of the Ad5 and Ad12 E1B 55K proteins in oncogenicity. g. Determine if the products of viral genes outside the El transforming region influence the oncogenic capacity of Ad5 and Ad12. h. Explore the basis for the strong susceptibility of Hooded Lister rats to tumor induction by Ad12.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA032940-12A3
Application #
2088438
Study Section
Experimental Virology Study Section (EVR)
Project Start
1982-08-01
Project End
1998-09-29
Budget Start
1995-09-30
Budget End
1996-09-29
Support Year
12
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Carnegie-Mellon University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
052184116
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Williams, J F; Zhang, Y; Williams, M A et al. (2004) E1A-based determinants of oncogenicity in human adenovirus groups A and C. Curr Top Microbiol Immunol 273:245-88
Williams, J; Williams, M; Liu, C et al. (1995) Assessing the role of E1A in the differential oncogenicity of group A and group C human adenoviruses. Curr Top Microbiol Immunol 199 ( Pt 3):149-75
Telling, G C; Perera, S; Szatkowski-Ozers, M et al. (1994) Absence of an essential regulatory influence of the adenovirus E1B 19-kilodalton protein on viral growth and early gene expression in human diploid WI38, HeLa, and A549 cells. J Virol 68:541-7
Telling, G C; Williams, J (1994) Constructing chimeric type 12/type 5 adenovirus E1A genes and using them to identify an oncogenic determinant of adenovirus type 12. J Virol 68:877-87
Lamberti, C; Williams, J (1990) Differential requirement for adenovirus type 12 E1A gene products in oncogenic transformation. J Virol 64:4997-5007
Byrd, P J; Grand, R J; Breiding, D et al. (1988) Host range mutants of adenovirus type 12 E1 defective for lytic infection, transformation, and oncogenicity. Virology 163:155-65
Breiding, D E; Edbauer, C A; Tong, J Y et al. (1988) Isolation and characterization of adenovirus type 12 E1 host-range mutants defective for growth in nontransformed human cells. Virology 164:390-402
Edbauer, C; Lamberti, C; Tong, J et al. (1988) Adenovirus type 12 E1B 19-kilodalton protein is not required for oncogenic transformation in rats. J Virol 62:3265-73
Eager, K B; Williams, J; Breiding, D et al. (1985) Expression of histocompatibility antigens H-2K, -D, and -L is reduced in adenovirus-12-transformed mouse cells and is restored by interferon gamma. Proc Natl Acad Sci U S A 82:5525-9